Renaissance Capital logo

ARGX News

US IPO Weekly Recap: 3 deals post double-digit returns

BEDU

Three IPOs raised $363 million in the past week. The two biotechs and a Chinese school operator popped an average of 21%, helping raise the year-to-date average to 8.3%. Just one company joined the calendar, micro-cap gunshot detector ...read more

Antibody biotech argenx prices upsized IPO at $17

Argenx logo

argenx, which is developing antibody therapies for rare autoimmune diseases and cancer, raised $100 million by offering 5.9 million ADSs at $17. argenx plans to list on the Nasdaq under the symbol ARGX. Cowen & Company and Piper Jaffray acted as lead...read more

argenx, a rare disease biotech harnessing llama DNA, raises proposed IPO deal size to $83 million

Argenx logo

argenx, which is developing antibody therapies for rare autoimmune diseases and cancer, raised the proposed deal size for its upcoming IPO on Tuesday. The Breda, Netherlands-based company now plans to raise $83 million by offering 5.0 million ADSs at a...read more

US IPO Week Ahead: Chinese international school operator and 3 biotechs

BEDU

There are four deals on the calendar for the week ahead. Chinese international school operator Bright Scholar Education is leading the week with a $135 million offering. Three biotechs are also expected to price deals, raising a total of $177 million. ...read more